title: Jaydess® levonorgestrel intrauterine system.
authors.affiliation: Director, Faculty of Sexual & Reproductive Healthcare (FSRH) Clinical Effectiveness Unit, Glasgow, UK.
authors.forename: Louise
authors.initials: L
authors.lastname: Melvin
authors.affiliation: Researcher, FSRH Clinical Effectiveness Unit, Glasgow, UK.
authors.forename: John
authors.initials: J
authors.lastname: Scott
authors.affiliation: Researcher, FSRH Clinical Effectiveness Unit, Glasgow, UK.
authors.forename: Julie
authors.initials: J
authors.lastname: Craik
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D019544:Equipment Failure Analysis; D004869:Equipment Safety; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects / Q000592:standards*; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000009:adverse effects*; D011247:Pregnancy; D018873:Pregnancy Rate / Q000639:trends; D011271:Pregnancy, Ectopic / Q000453:epidemiology / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D006113:United Kingdom; D014592:Uterine Hemorrhage / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology
chemical_list: D016912:Levonorgestrel
keywords: Family Planning Service Provision; Intrauterine Systems